These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 28398755

  • 1. Inhibitors of 15-Prostaglandin Dehydrogenase To Potentiate Tissue Repair.
    Antczak MI, Zhang Y, Wang C, Doran J, Naidoo J, Voruganti S, Williams NS, Markowitz SD, Ready JM.
    J Med Chem; 2017 May 11; 60(9):3979-4001. PubMed ID: 28398755
    [Abstract] [Full Text] [Related]

  • 2. TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration.
    Zhang Y, Desai A, Yang SY, Bae KB, Antczak MI, Fink SP, Tiwari S, Willis JE, Williams NS, Dawson DM, Wald D, Chen WD, Wang Z, Kasturi L, Larusch GA, He L, Cominelli F, Di Martino L, Djuric Z, Milne GL, Chance M, Sanabria J, Dealwis C, Mikkola D, Naidoo J, Wei S, Tai HH, Gerson SL, Ready JM, Posner B, Willson JK, Markowitz SD.
    Science; 2015 Jun 12; 348(6240):aaa2340. PubMed ID: 26068857
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 15-Hydroxyprostaglandin dehydrogenase inhibitor prevents contrast-induced acute kidney injury.
    Kim BW, Kim HJ, Kim SH, Baik HJ, Kang MS, Kim DH, Markowitz SD, Kang SW, Bae KB.
    Ren Fail; 2021 Dec 12; 43(1):168-179. PubMed ID: 33459127
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of 15-PGDH prevents ischemic renal injury by the PGE2/EP4 signaling pathway mediating vasodilation, increased renal blood flow, and increased adenosine/A2A receptors.
    Kim HJ, Kim SH, Kim M, Baik H, Park SJ, Kang MS, Kim DH, Kim BW, Markowitz SD, Bae KB.
    Am J Physiol Renal Physiol; 2020 Dec 01; 319(6):F1054-F1066. PubMed ID: 33135478
    [Abstract] [Full Text] [Related]

  • 7. A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support.
    Desai A, Zhang Y, Park Y, Dawson DM, Larusch GA, Kasturi L, Wald D, Ready JM, Gerson SL, Markowitz SD.
    Haematologica; 2018 Jun 01; 103(6):1054-1064. PubMed ID: 29472361
    [Abstract] [Full Text] [Related]

  • 8. Structure-activity relationship studies and biological characterization of human NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors.
    Duveau DY, Yasgar A, Wang Y, Hu X, Kouznetsova J, Brimacombe KR, Jadhav A, Simeonov A, Thomas CJ, Maloney DJ.
    Bioorg Med Chem Lett; 2014 Jan 15; 24(2):630-5. PubMed ID: 24360556
    [Abstract] [Full Text] [Related]

  • 9. Recent advances in studies of 15-PGDH as a key enzyme for the degradation of prostaglandins.
    Sun CC, Zhou ZQ, Yang D, Chen ZL, Zhou YY, Wen W, Feng C, Zheng L, Peng XY, Tang CF.
    Int Immunopharmacol; 2021 Dec 15; 101(Pt B):108176. PubMed ID: 34655851
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In silico screening and in vivo experimental validation of 15-PGDH inhibitors from traditional Chinese medicine promoting liver regeneration.
    Feng C, Qiao C, Ji W, Pang H, Wang L, Feng Q, Ge Y, Rui M.
    Int J Biol Macromol; 2024 Aug 15; 274(Pt 1):133263. PubMed ID: 38901515
    [Abstract] [Full Text] [Related]

  • 13. Control of the intracellular levels of prostaglandin E₂ through inhibition of the 15-hydroxyprostaglandin dehydrogenase for wound healing.
    Choi D, Piao YL, Wu Y, Cho H.
    Bioorg Med Chem; 2013 Aug 01; 21(15):4477-84. PubMed ID: 23791868
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Wound healing effects of new 15-hydroxyprostaglandin dehydrogenase inhibitors.
    Piao YL, Seo SY, Lim SC, Cho H.
    Prostaglandins Leukot Essent Fatty Acids; 2014 Dec 01; 91(6):325-32. PubMed ID: 25458900
    [Abstract] [Full Text] [Related]

  • 16. 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis.
    Myung SJ, Rerko RM, Yan M, Platzer P, Guda K, Dotson A, Lawrence E, Dannenberg AJ, Lovgren AK, Luo G, Pretlow TP, Newman RA, Willis J, Dawson D, Markowitz SD.
    Proc Natl Acad Sci U S A; 2006 Aug 08; 103(32):12098-102. PubMed ID: 16880406
    [Abstract] [Full Text] [Related]

  • 17. High-affinity inhibitors of human NAD-dependent 15-hydroxyprostaglandin dehydrogenase: mechanisms of inhibition and structure-activity relationships.
    Niesen FH, Schultz L, Jadhav A, Bhatia C, Guo K, Maloney DJ, Pilka ES, Wang M, Oppermann U, Heightman TD, Simeonov A.
    PLoS One; 2010 Nov 02; 5(11):e13719. PubMed ID: 21072165
    [Abstract] [Full Text] [Related]

  • 18. Expression of NAD+ dependent 15-hydroxyprostaglandin dehydrogenase and protection of prostaglandins in human hair follicle.
    Michelet JF, Colombe L, Gautier B, Gaillard O, Benech F, Pereira R, Boulle C, Dalko-Csiba M, Rozot R, Neuwels M, Bernard BA.
    Exp Dermatol; 2008 Oct 02; 17(10):821-8. PubMed ID: 18328086
    [Abstract] [Full Text] [Related]

  • 19. Effect of 15-hydroxyprostaglandin dehydrogenase inhibitor on wound healing.
    Seo SY, Han SI, Bae CS, Cho H, Lim SC.
    Prostaglandins Leukot Essent Fatty Acids; 2015 Jun 02; 97():35-41. PubMed ID: 25899574
    [Abstract] [Full Text] [Related]

  • 20. Action of prostaglandin dehydrogenase inhibitors on prostaglandin uptake in rat isolated lung.
    Bakhle YS.
    Br J Pharmacol; 1979 Apr 02; 65(4):635-9. PubMed ID: 435688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.